Jubilant Biosys Hiring Trainee Research Associate-Analytical

FDA’s New Guidelines for Adaptive Trial Designs: What Researchers Need to Know In an era where efficiency and flexibility are increasingly valued in clinical research, adaptive trial designs offer a dynamic alternative to traditional, rigid study models. Recently, the U.S. Food and Drug Administration (FDA) updated its guidance on adaptive clinical trials, providing clearer direction […]

Decentralized Clinical Trials (DCTs): The Future of Patient-Centric Research In the evolving landscape of clinical research, Decentralized Clinical Trials (DCTs) are reshaping how studies are conducted—bringing research directly to the patient, rather than requiring patients to come to the research site. As healthcare systems worldwide aim to be more inclusive, accessible, and efficient, DCTs stand […]

CRISPR and Genome Editing: Are We Ready for Clinical Application? Over the past decade, CRISPR-Cas9 has transformed from a powerful laboratory tool to a potential clinical game-changer. From correcting genetic mutations to engineering immune cells to fight cancer, genome editing holds immense promise. But as science moves rapidly, the question arises: Are we truly ready […]

How Patient-Centric Approaches Are Redefining Clinical Trial Success The traditional model of clinical trials has long focused on meeting regulatory endpoints—efficacy, safety, and statistical significance. While these metrics remain crucial, they often fail to capture the full picture of what success means from a patient’s perspective. Today, a transformative shift is taking place. Clinical trials […]

Synthetic Control Arms: Reducing the Need for Placebo Groups in Clinical Trials The traditional model of randomized controlled trials (RCTs), long considered the gold standard in clinical research, faces growing scrutiny—especially from patients with serious or rare conditions who are reluctant to risk being assigned to placebo groups. In this context, Synthetic Control Arms (SCAs) […]

The Growing Role of Pharmacogenomics in Personalized Clinical Trials In recent years, the landscape of clinical research has been reshaped by the advent of personalized medicine, a movement that recognizes the uniqueness of every patient’s genetic makeup. At the heart of this transformation lies pharmacogenomics—the study of how an individual’s genetic profile influences their response […]

  How Blockchain is Enhancing Transparency and Security in Clinical Trials In the complex ecosystem of clinical research, trust, transparency, and data integrity are non-negotiable. However, challenges such as data tampering, lack of traceability, selective reporting, and delays in trial disclosures continue to undermine public trust and scientific progress. Blockchain technology—best known for its role […]

AI and Machine Learning in Clinical Trial Design: Revolution or Risk? Integrating Artificial Intelligence (AI) and Machine Learning (ML) into clinical research transforms how trials are designed, conducted, and analyzed. As the pharmaceutical and biotechnology industries face mounting pressure to reduce costs, shorten timelines, and improve outcomes, AI and ML have emerged as powerful tools […]

New Horizons in Cancer Immunotherapy Trials Cancer immunotherapy has redefined the landscape of oncology, offering new hope where conventional therapies often fall short. By harnessing the power of the body’s own immune system, immunotherapy has demonstrated durable responses across a variety of cancers. However, despite these advances, challenges remain—particularly regarding response variability, toxicity, and resistance. […]